GN Store Nord A/S Meet the Management Event (Virtual) Transcript

The following is excerpted from the question-and-answer section of the transcript.

Question: Julien Ouaddour - BNP Paribas Exane, Research Division - Analyst : So 2 very quick ones for you, Scott. First of all, have you heard about Bose maybe walking down and closing its hearing aids business, I mean, even before the start of the OTC regulation implementation, et cetera? So any thoughts here will be super helpful. And second question, still on OTC and kind on the Jabra Enhance Plus, it seems that you charge $200 for service with the device within Beltone. So first of all, is it mandatory for the customers? And do you think that this is, let's say, the ideal long-term business model for OTC? I mean, do you think competition will follow with similar offer, et cetera?

Question: Julien Ouaddour - BNP Paribas Exane, Research Division - Analyst : Yes. Can you hear me?

Question: Julien Ouaddour - BNP Paribas Exane, Research Division - Analyst : Okay. Perfect. Yes. So I have, let's say, 2 questions. So the first one on SteelSeries and on the profitability. So I know, Rene, that you sort of guide for 14% to 15% EBITDA margin this year, I think, for SteelSeries. The question is more over the midterm. Do you think that SteelSeries might achieve a sort of closer profitability level than the core GN Audio, like in the 20s, for example? That's my first question. And sorry, Rene, to, let's say, come back on it, but I would like just to jump back on the audio guidance for Q1. So basically, my understanding is that Q1 will be a bit below the initial guidance of minus 25% sales decline as some as, let's say, slipped into Q2. So just to be sure I am right or there is, let's say, still a scenario in which you can hit the minus 25% in Q1. I don't know if you can ship enough products before March 31.